Skip to main content
Premium Trial:

Request an Annual Quote

Danaher Initiates Guidance for 2017

NEW YORK (GenomeWeb) – Danaher today released its earnings guidance for 2017, saying that it anticipates net earnings per share of $3.13 to $3.23.

On an adjusted basis, the company expects earnings of $3.85 to $3.95 per share, which assumes core revenue growth of 3 percent to 4 percent over 2016. The current average analyst estimate for earnings per share in 2017 is $3.95.

"This has been an exciting year for Danaher. We closed approximately $5 billion in acquisitions across all five of our platforms — including the larger strategic acquisitions of Cepheid and Phenomenex; completed the separation of Fortive; and have driven solid core revenue growth, operating margin expansion, and cash flow performance," Danaher CEO Thomas Joyce said in a statement. "We believe we have an outstanding multi-industry, science, and technology company that has tremendous growth and margin opportunities."

In October, the firm said that it anticipated Q4 adjusted earnings per share of $1.01 to $1.05, and adjusted earnings per share of $3.57 to $3.61 for 2016.

Danaher's shares rose less than 1 percent to $79.08 in morning trading on the New York Stock Exchange.